Source - SMW
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p).

Related Charts

GlaxoSmithKline (GSK)

-16.00p (-1.01%)
delayed 13:01PM